Covid 19 Infection In A Patient Newly Diagnosed With Hiv Tb  Coinfection – A Case Report

Shivam Sanjay  Panchal; Janakkumar R  Khambholja; Nehal M  Shah; Poorvi Mansukhbhai  Aghara

doi:10.48165/ijabms.2022.243816

Authors

Shivam Sanjay Panchal Resident, Department of General Medicine, Smt NHL Municipal Medical College, Ahmedabad
Janakkumar R Khambholja MD/DNB in General Medicine, Professor, Department of General Medicine, Department of General Medicine, Smt NHL Municipal Medical College, Ahmedabad
Nehal M Shah MD in General Medicine, Assistant Professor, Department of General Medicine, Department of General Medicine, Smt NHL Municipal Medical College, Ahmedabad
Poorvi Mansukhbhai Aghara Resident, Department of Pathology, Smt NHL Municipal Medical College, Ahmedabad

DOI:

https://doi.org/10.48165/ijabms.2022.243816

Keywords:

HIV/TB coinfection, COVID 19 with HIV/TB, immune reconstitution inflammatory syndrome (IRIS), TB lymphadenopathy

Abstract

Introduction -COVID 19 refers to infectious disease caused due to infection by SARS-CoV-2, which resulted in a pandemic in the year 2020, with continuing effects in some regions of the world. It chiefly causes a respiratory illness, with features ranging from fever and mild cough to breathlessness and hypoxemia, along with a secondary hyperinflammatory and hypercoagulable state. HIV/TB coinfection is, on its own, associated with a poor outcome, due to an increased propensity to secondary infections. Method & Discussion :Here, we describe the case of an elderly male admitted for COVID 19, but diagnosed as having HIV/TB coinfection, with generalised lymphadenopathy and other constitutional features. Treatment was instituted per protocol. He also developed a treatment-related immune reconstitution inflammatory syndrome (IRIS), which was appropriately managed, and was eventually discharged following recovery from COVID-19. ART and AKT, with prophylactic medications, were ongoing at the time of discharge.
Conclusion :– HIV/TB coinfection is associated with a poor prognosis. There are no specific recommendations for management of superadded COVID-19. The number of reported cases is low, and treatment had been given for the respective disorders as per prevailing local protocols.